FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to compounds of general formula
where there are R3/R3', R4/R4' and R5/R5' where at least one of either R4/R4' or R5/R5' always represents a fluorine atom, and the other radical values are disclosed in the description.
EFFECT: making the compounds which are γ-secretase inhibitors, and can be effective in treating Alzheimer's disease or advanced cancers, including but not limited to carcinoma of uterine cervix and breast carcinoma and malignant tumours of hematopoietic system.
15 cl, 3 tbl, 18 ex
Title | Year | Author | Number |
---|---|---|---|
N-REPLACED BENZOSULPHONAMIDES | 2004 |
|
RU2364587C2 |
CYCLOALKANE DERIVATIVE | 2013 |
|
RU2635354C2 |
BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | 2017 |
|
RU2769827C2 |
SODIUM CHANNEL BLOCKER | 2016 |
|
RU2705578C1 |
SODIUM CHANNEL MODULATORS FOR THE TREATMENT OF PAIN | 2014 |
|
RU2669367C2 |
PYRIDOXAZINONE DERIVATIVES AS TNAP INHIBITORS | 2016 |
|
RU2715704C2 |
NON-PEPTIDE ANTAGONISTS GnRH | 2003 |
|
RU2329251C2 |
BRIDGED N-CYCLYC SULPHONAMIDO-INHIBITORS OF GAMMA-SECRETASE | 2006 |
|
RU2422443C2 |
MODULATORS OF ATP-BINDING TRANSPORTERS | 2010 |
|
RU2552353C2 |
DERIVATIVES OF ALPHA-(N-SULFONAMIDO)ACETAMIDE AS INHIBITORS OF BETA-AMYLOID | 2002 |
|
RU2300518C2 |
Authors
Dates
2011-05-27—Published
2006-08-02—Filed